Elucidating the effect of crystallization on drug release from amorphous solid dispersions in soluble and insoluble carriers

AT Ojo, C Ma, PI Lee - International Journal of Pharmaceutics, 2020 - Elsevier
The development of amorphous solid dispersions (ASDs) is one way to overcome the
bioavailability challenges of poorly water-soluble active pharmaceutical ingredients (APIs) …
被引用次数：23 相关文章

Elucidating the effect of crystallization on drug release from amorphous solid dispersions in soluble and insoluble carriers

AT Ojo, C Ma, PI Lee - International journal of …, 2020 - pubmed.ncbi.nlm.nih.gov
The development of amorphous solid dispersions (ASDs) is one way to overcome the
bioavailability challenges of poorly water-soluble active pharmaceutical ingredients (APIs) …

Elucidating the effect of crystallization on drug release from amorphous solid dispersions in soluble and insoluble carriers.

AT Ojo, C Ma, PI Lee - International Journal of Pharmaceutics, 2020 - europepmc.org
The development of amorphous solid dispersions (ASDs) is one way to overcome the
bioavailability challenges of poorly water-soluble active pharmaceutical ingredients (APIs) …
[PDF] google.com

[PDF][PDF] Elucidating the effect of crystallization on drug release from amorphous solid dispersions in soluble and insoluble carriers

AT Ojo, C Ma, PI Lee - International Journal of Pharmaceutics, 2020 - drive.google.com
The development of amorphous solid dispersions (ASDs) is one way to overcome the
bioavailability challenges of poorly water-soluble active pharmaceutical ingredients (APIs) …